LU-177-PSMA TREATMENT FOR METASTATIC PROSTATE CANCER – CASE EXAMPLES OF MIRACLE RESPONSES

Prostate specific membrane antigen (PSMA) is expressed in unfavorable prostate cancer. PSMA is basis for new diagnostics and theranostics. 177Lu-PSMA radioligand therapy is mainly used for patients with endstage prostate cancer. This report describes two patients: one patient with a multiple recurre...

Full description

Bibliographic Details
Main Authors: K. Kairemo, T. Joensuu
Format: Article
Language:Russian
Published: State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2018-03-01
Series:Vestnik Urologii
Subjects:
Online Access:https://www.urovest.ru/jour/article/view/193